A Phase III, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial of d-Threo-Methylphenidate HCl in Brain Tumor Patients Receiving Radiation Therapy
- 1 December 2007
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 69 (5), 1496-1501
- https://doi.org/10.1016/j.ijrobp.2007.05.076
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844)European Journal Of Cancer, 1998
- Methylphenidate treatment of negative symptoms in patients with dementiaThe Journal of Neuropsychiatry and Clinical Neurosciences, 1997
- USE OF STIMULANTS IN THE MEDICALLY ILLPsychiatric Clinics of North America, 1996
- Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: A preliminary double-blind placebo-controlled studyArchives Of Physical Medicine and Rehabilitation, 1996
- Methylphenidate effect on attention deficit in the acutely brain-injured adultArchives Of Physical Medicine and Rehabilitation, 1996
- Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatmentThe Journal of Neuropsychiatry and Clinical Neurosciences, 1995
- Medical Use of Psychostimulants: An OverviewThe International Journal of Psychiatry in Medicine, 1995
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Cognitive functions and quality of life in patients with low‐grade gliomas: The impact of radiotherapyAnnals of Neurology, 1994
- Cognitive functioning in long-term survivors of high-grade gliomaJournal of Neurosurgery, 1994